Skip to main content

Table 1 Effects of HFD and AuNP treatment on anthropometric parameters

From: Gold nanoparticles as cell regulators: beneficial effects of gold nanoparticles on the metabolic profile of mice with pre-existing obesity

 

Chow

OB

OB-EAu

OB-LAu

OB-HAu

Body weight initial (g)

23.0 ± 0.3

22.9 ± 0.3

23.0 ± 0.3

23.0 ± 0.3

22.9 ± 0.4

Body weight at 10 weeks (g)

30.1 ± 0.6

44.2 ± 0.8*

44.2 ± 0.6*

44.7 ± 0.6*

44.3 ± 0.6*

Body weight at 15 weeks (g)

29.9 ± 0.5

45.6 ± 0.8*

43.0 ± 0.7*,†

40.0 ± 1.2*,†

44.6 ± 0.5*

Energy intake (kJ/day)

44.6 ± 1.0

55.7 ± 1.9*

60.6 ± 1.9*

51.6 ± 4.1*

59.0 ± 2.0*

Liver (g)

1.41 ± 0.04

2.85 ± 0.19*

2.64 ± 0.12*

2.10 ± 0.13*,†

2.66 ± 0.12*

Liver (%)

4.74 ± 0.13

6.20 ± 0.31*

6.10 ± 0.22*

5.20 ± 0.19†

5.94 ± 0.23*

Retroperitoneal fat (g)

0.14 ± 0.02

0.71 ± 0.04*

0.56 ± 0.04*,†

0.51 ± 0.05*,†

0.62 ± 0.02*

Retroperitoneal fat (%)

0.46 ± 0.06

1.56 ± 0.08*

1.30 ± 0.07*,†

1.23 ± 0.09*,†

1.38 ± 0.04*

Mesenteric fat (g)

0.43 ± 0.03

1.12 ± 0.04*

1.19 ± 0.07*

1.02 ± 0.09*

1.20 ± 0.04*

Mesenteric fat (%)

1.45 ± 0.08

2.44 ± 0.10*

2.76 ± 0.13*

2.53 ± 0.17*

2.69 ± 0.08*

Epididymal fat (g)

0.51 ± 0.04

2.08 ± 0.08*

2.43 ± 0.08*,†

1.81 ± 0.12*,†

2.25 ± 0.08*

Epididymal fat (%)

1.17 ± 0.12

4.57 ± 0.21*

5.66 ± 0.19†

4.54 ± 0.29*

5.05 ± 0.19*

  1. Results are expressed as mean ± S.E.M. Data were analysed by one-way ANOVA followed by post hoc Bonferroni test
  2. * P < 0.05 vs Chow; † P < 0.05 vs OB. n = 9–15